Literature DB >> 24830382

Subconjunctival Injection of Fluconazole in the Treatment of Fungal Alternaria Keratitis.

Shih-Hao Tsai1, Yen-Chun Lin1, Huan-Chen Hsu1, Yan-Ming Chen1,2.   

Abstract

PURPOSE: We report two cases of Alternaria keratitis refractory to the conventional antifungal medical treatment successfully treated with subconjunctival fluconazole injection.
METHODS: Report of two cases.
RESULTS: After subconjunctival injection of fluconazole (2 mg/mL) 0.5 mL twice a day for 5 days then once a day till 14 days, two cases of Alternaria keratitis refractory to the conventional antifungal medical treatment were successfully treated. No severe local and systemic side effects were found in these two patients.
CONCLUSIONS: Alternaria keratitis has a varied clinical presentation and suspicion must be maintained for unusual causes of infectious keratitis. Alternaria keratitis can be difficult to eradicate even with traditional antifungals such as amphotericin B and natamycin. Subconjunctival injection of fluconazole could be effective for Alternaria keratitis unresponsive to conventional antifungal medical treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24830382     DOI: 10.3109/09273948.2014.916308

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

Review 1.  Review of clinical and basic approaches of fungal keratitis.

Authors:  Jie Wu; Wen-Song Zhang; Jing Zhao; Hong-Yan Zhou
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

2.  An Atypical Etiology of Fungal Keratitis Caused by Roussoella neopustulans.

Authors:  Morgana F Voidaleski; Flavio Queiroz-Telles; Hugo T Itikawa; Guilherme G Müller; Bruna J F S Lima; Lucas E Trevisoli; Regielly C R Cognialli; Roberta C L Crispim; Vania A Vicente
Journal:  J Fungi (Basel)       Date:  2022-05-15

3.  Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies.

Authors:  Mariano Mora-Pereira; Eva M Abarca; Sue Duran; William Ravis; Richard J McMullen; Britta M Fischer; Yann-Huei Phillip Lee; Anne A Wooldridge
Journal:  BMC Vet Res       Date:  2020-04-16       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.